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Purpose: To retrospectively evaluate pulmonary artery (PA) clot
load scores and computed tomographic (CT) cardiovascu-
lar parameters as predictors of mortality in patients with
severe pulmonary embolism (PE).
Materials and
Methods:
Institutional review board approval was obtained with
waiver of informed consent. A total of 82 consecutive
patients (42 women, 40 men; mean age  standard devia-
tion, 61 years  15) were admitted to the intensive care
unit for PE-related conditions and were evaluated by using
CT pulmonary angiography. Two independent readers
who were blinded to clinical outcome quantified PA clot
load by using four scoring systems. Cardiovascular mea-
surements included right ventricular (RV) and left ventric-
ular (LV) short-axis measurements; RV short axis to LV
short axis (RV/LV) ratios; main PA, ascending aorta, azy-
gos vein, and superior vena cava diameters; and main PA
diameter to aorta diameter ratios. Reflux of contrast me-
dium into the inferior vena cava, leftward bowing of the
interventricular septum, pleural or pericardial effusion,
pulmonary consolidation, infarct, platelike atelectasis, and
mosaic ground-glass opacity were also recorded. Results
were correlated with patient outcome during hospital stay
by using the Wilcoxon rank sum and 2 tests.
Results: Twelve patients died within 1–14 days. RV and LV short
axis; RV/LV ratio; azygos vein, superior vena cava, and
aorta diameters; and contrast medium reflux into the infe-
rior vena cava were significantly different between survi-
vors and nonsurvivors (P  .05). No significant relation-
ship was found between PA clot load and mortality rate.
RV/LV ratio and azygos vein diameter allowed correct
prediction of survival in 89% of patients (P  .001).
Conclusion: RV/LV ratio and azygos vein diameter are predictors of
mortality in patients with severe PE.
 RSNA, 2006
1 From the Departments of Medical Imaging (B.G., V.W.,
R.F.D.) and Medicine (A.G., B.L., V.D.), University Hospital
of Liege, B35 Sart Tilman, B-4000 Liege, Belgium; De-
partment of Mathematics, University of Liege, Liege, Bel-
gium (P.G.); and Department of Radiology, University
Erasme Hospital, University of Brussels, Brussels, Belgium
(P.A.G.). From the 2003 RSNA Annual Meeting. Received
January 17, 2005; revision requested March 22; revision
received May 13; accepted June 13; final version ac-




















884 Radiology: Volume 239: Number 3—June 2006
I f untreated, pulmonary embolism(PE) is fatal in up to 30% of patients,but the death rate can be reduced to
2%–10% if PE is diagnosed and treated
promptly (1–3). When PE is fatal, pa-
tients usually die after right ventricular
(RV) failure and circulatory collapse,
which frequently occurs within the first
hours after admission (1,2,4). This sug-
gests that RV dysfunction should be di-
agnosed rapidly to identify patients,
even those with normal blood pressure,
who could benefit from fibrinolytic ther-
apy (3–10). Nevertheless, because the
current forms of fibrinolytic therapy in-
crease costs and can produce dramatic
side effects, the diagnostic method for
detecting RV dysfunction should be
highly specific (3,11).
Computed tomographic (CT) pul-
monary angiography can be used to
identify clots within distal pulmonary
arteries (PAs) with a specificity of 95%
and can demonstrate alternative diag-
noses and underlying lung diseases.
Consequently, CT pulmonary angiogra-
phy has become the first imaging exam-
ination performed in patients suspected
of having PE (12–15). Although echo-
cardiography is currently used to detect
RV dysfunction, CT pulmonary angiog-
raphy could replace this technique be-
cause it can be used to diagnose PE and
assess RV function simultaneously.
Some investigators (16–22) have
evaluated the accuracy of CT scoring sys-
tems for PA clot load, and others have
reported CT findings for RV dysfunction
(19,20,22–27). Few, however, have in-
vestigated the relationships between clot
load score, RV dysfunction, and patient
outcome (20–22,26,27). The aim of our
study was to retrospectively evaluate PA
clot load scores and CT cardiovascular
parameters as predictors of mortality in
patients with severe PE.
Materials and Methods
Patients and Outcome
The institutional review board of the Uni-
versity Hospital of Liege approved this
study with waiver of informed consent.
From January 1995 to December 2001,
90 consecutive patients were admitted to
the intensive care unit for severe acute
PE-related conditions. In 84 patients, PE
was diagnosed by using CT pulmonary
angiography, which has been the primary
imaging technique in our hospital since
1995. In the remaining six patients, PE
was diagnosed by means of ventilation-
perfusion lung scanning (two patients),
digital subtraction pulmonary angiogra-
phy (two patients), or echocardiography,
which showed major dilation of the right
cardiac chambers and clinical findings
suggestive of PE (two patients). Of the 84
CT pulmonary angiograms, two were not
available for review. Therefore, our final
study group included 82 patients of which
42 (51%) were women and 40 (49%)
were men (63 outpatients [77%] and 19
inpatients [23%] before admission to the
intensive care unit). Mean patient age 
standard deviation was 61 years  15
(range, 22–84 years). On admission to
the intensive care unit, clinical presenta-
tion, which was assessed according to the
classification system proposed by Stein et
al (28), included pulmonary infarction or
hemorrhage syndrome in 21 patients
(26%), isolated dyspnea in 29 patients
(35%), and circulatory failure in 32 pa-
tients (39%).
Once PE was diagnosed, treatment
was initiated according to the estab-
lished guidelines (29) and included in-
travenous heparin in 61 patients (74%)
and systemic thrombolysis in 21 pa-
tients (26%). In addition, the Tren-
delenburg surgical procedure was per-
formed in six patients (7%), and an in-
ferior vena cava filter was inserted in
five patients (6%). No patient under-
went mechanical thrombolysis. Fifteen
patients (18%) required mechanical
ventilation.
Patient outcome during hospital
stay was retrospectively analyzed on the
basis of medical charts by one author
(A.G.). As a first step, the outcome was
evaluated in terms of overall in-hospital
mortality. As a second step, the out-
come was restricted to early mortality
(ie, within 48 hours after the onset of
symptoms).
CT Pulmonary Angiography
CT pulmonary angiographic acquisi-
tion.—CT pulmonary angiograms were
obtained with a commercially available
CT scanner (PQ 5000; Philips, Eind-
hoven, the Netherlands). Before scan-
ning, patients were trained to hold their
breath in full inspiration for 10–40 sec-
onds while in the supine position. For
patients who underwent mechanical
ventilation, ventilation was manually
suspended in deep inspiration. Scan-
ning was performed during shallow
breathing in patients who were short of
breath. A caudocranial helical acquisi-
tion was obtained with a collimation of 5
mm (11 patients), 3 mm (14 patients),
or 2 mm (57 patients) and a pitch of
1.5–2.0, which was varied according to
breath-hold capabilities.
Acquisition time was 1 second per
rotation, tube current was 125 mA, and
peak voltage was 130 kVp. Images were
reconstructed by using a soft-tissue ker-
nel, with an increment of 1–3 mm and a
matrix of 512  512. The z-axis cover-
age started 2 cm below the diaphragm
and extended up to the aorta, thereby
enabling visualization of the heart and
PAs, which included the subsegmental
arteries. Twenty seconds before acqui-
sition began, a 140-mL peripheral intra-
venous injection of 30% iodinated con-
trast medium (Xenetix; Guerbet,
Aulnay-sous-Bois, France) was adminis-
tered at a flow rate of 3 mL/sec. The
results of CT pulmonary angiography




Az  area under the receiver operating characteristic
curve
LV  left ventricular
PA  pulmonary artery
PE  pulmonary embolism
RV  right ventricular
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were transmitted immediately to the
physician for patient care but were not
included in the present study. Images
were stored on CD-ROMs.
CT pulmonary angiographic read-
ing.—Images were reviewed on a work-
station (Voxel Q; Philips) by two inde-
pendent readers. Reader 1 (B.G.) was a
chest radiologist with 12 years of expe-
rience reading thoracic CT scans, and
reader 2 (V.W.) was a 5th-year radiol-
ogy resident with 3 years of experience
reading CT pulmonary angiograms. The
diagnosis of PE was based on criteria
recommended by Ghaye et al (12).
Readers scored PA clot load, evaluated
cardiovascular measurements, and as-
sessed qualitative findings as detailed
below. Readers were blinded to clinical
data (with the exception of patient ad-
mission to the intensive care unit), to
the results of other imaging techniques,
and to patient outcome.
The presence and location of arte-
rial clots and the degree of arterial ob-
struction were scored by using the sys-
tems proposed by Miller et al (30),
Walsh et al (31), Qanadli et al (17), and
Mastora et al (18). For comparison,
each score was expressed as the per-
centage of the PA that was obstructed.
Percentages were calculated by dividing
the value obtained with each system by
the maximum possible value for that
particular system and then multiplying
by 100. Details on each scoring system
are presented in the Appendix.
Cardiac measurements for the RV
and left ventricular (LV) short axes
were obtained. Axes were measured in
diastole on a single transverse scan per-
pendicular to the long axis of the heart
and were defined as the largest distance
between the inner aspect of the inter-
ventricular septum and the free wall of
the ventricle (20,22,26,27). The RV/LV
ratio was then calculated from these
measurements.
Vascular measurements for the di-
ameters of the main PA lumen, ascend-
ing aorta, azygos vein, and superior
vena cava were also obtained. The ratio
of the main PA diameter to the aorta
diameter was calculated from these fig-
ures. Vascular measurements were ob-
tained on adjusted multiplanar refor-
matted images in the plane that was
perpendicular to the long axis of the
vessel being considered and were ac-
quired by using electronic calipers. The
diameter of the main PA lumen was
measured proximal to its branching di-
vision. Measurements were taken of the
aorta at the level of the middle third of
its ascending portion, of the portion of
the azygos vein facing the right tracheal
wall, and of the superior vena cava at
the level of the azygos arch. The follow-
ing observations were also recorded:
reflux of contrast medium into the infe-
rior vena cava, convex leftward bowing
of the interventricular septum, pleural
and/or pericardial effusion, and pulmo-
nary findings, including pulmonary con-
solidation, infarct, platelike atelectasis,
and mosaic ground-glass opacity.
Statistical Analysis
Statistical analyses were performed with
a personal computer by using a commer-
cially available software program (Statis-
tica, version 6.1; StatSoft, Tulsa, Okla).
Following the Kolmogorov-Smirnov test,
data with a normal distribution were ex-
pressed as means  standard deviations,
and data with a skewed distribution were
expressed as medians, with first and third
quartiles.
Interobserver variations were eval-
uated by means of the Spearman rank
correlation coefficient (rs) for continu-
ous variables and by using Cohen  sta-
tistics for qualitative variables. If the in-
terobserver agreement was either good
(  0.61–0.80) or excellent (  0.81–
1.00), further calculations for qualita-
tive variables were based on the results
of the more experienced reader (reader
1) (32).
To investigate the relationship be-
tween CT findings and patient outcome,
we used the Wilcoxon rank sum test to
evaluate differences in the distributions
of CT measurements between survivors
and nonsurvivors; the 2 test was used
to evaluate differences in qualitative
findings. Correlations between continu-
ous variables were determined by using
the Pearson coefficient (r).
The relationship between the sensi-
tivity and specificity of CT measure-
ments was investigated by means of re-
ceiver operating characteristic curves.
The areas under the receiver operating
characteristic curves (Az values) were
calculated and compared. The thresh-
old value for which sensitivity equaled
specificity was calculated for measure-
ments with an Az value that was signifi-
cantly different from 0.5 (33).
All CT parameters were submitted
to univariate logistic regression analysis
in order to identify cutoff values associ-
ated with a probability of death of 5%,
10%, 20%, 30%, 40%, and 50%. Fi-
nally, discriminating parameters were
subjected to multivariate regression
analysis in order to detect parameters
that most reflected the probability of
death. From these results, odds ratios
were calculated. For all tests, a P value
of .05 was considered to indicate a sta-
tistically significant difference.
Results
Parameters Evaluated and Patient
Outcome
All CT parameters except reflux into the
inferior vena cava were assessable in all
patients. Reflux was not assessable in 32
patients (39%) because the inferior
vena cava was not included in the CT
pulmonary angiographic range. Hospital
stay ranged from 1 to 68 days (mean, 15
days  10). Twelve patients (15%)
eventually died, with a median survival
of 2 days (first and third quartiles, 1 and
8 days).
CT Quantitative Measurements
PA clot load score.—The Spearman cor-
relation coefficient for comparisons be-
tween PA clot load scores of each scoring
system ranged from 0.770 to 0.967 (P 
.001), which indicated highly significant
correlations. No significant difference
was found between survivors and nonsur-
vivors (P .092–.215) (Table 1).
CT cardiovascular measurements.—
Comparison of cardiovascular measure-
ments between survivors and nonsurvivors
(Table 1) showed significant differences in
aorta diameter (P  .040), RV short axis
(P  .022), RV/LV ratio (P  .011), supe-
rior vena cava diameter (P  .001), and
azygos vein diameter (P  .001). When
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only early mortality was considered, the
RV/LV ratio (P .006), RV short axis (P
.018), LV short axis (P  .035), superior
vena cava diameter (P  .045) and azygos
vein diameter (P  .004) were also signifi-
cantly different between survivors and non-
survivors.
For the correlation between PA clot
load scores and cardiovascular mea-
surements (Table 2), Pearson correla-
tion coefficients were highest between
LV short axis, RV short axis, and RV/LV
ratio and PA clot load and lower (but
still significant) between azygos vein di-
ameter and PA clot load, as scored ac-
cording to Qanadli et al (17) and Mas-
tora et al (18).
For CT measurements that were
tested for their ability to predict sur-
vival, Az was significantly higher than
0.5 for aorta diameter (P .039), supe-
rior vena cava diameter (P .004), azy-
gos vein diameter (P  .003), and
RV/LV ratio (P  .009) (Table 3, Fig-
ure). These Az values, however, were
not significantly different (P  .389–
.865). For CT measurements for which
Az was significantly higher than 0.5, Ta-
ble 3 lists the threshold values for which
sensitivity equaled specificity.
For all quantitative CT measure-
ments for which significant differences
between survivors and nonsurvivors
were observed, we calculated the cutoff
values associated with probability of
death (Table 4). For all measurements,
a higher value indicated a higher proba-
bility of death.
CT Qualitative Findings
Reflux into the inferior vena cava was
the only finding that differed signifi-
cantly between survivors and nonsurvi-
vors (P  .026) (Table 5). When only
early mortality was considered, reflux
(P .016) and pericardial effusion (P
.030) were significantly different be-
tween survivors and nonsurvivors.
Among all CT pulmonary angiogra-
phy measurements, RV/LV ratio and
azygos vein diameter were the best dis-
criminators of mortality and enabled
correct prediction of survival in 89% of
patients (P  .001). The odds ratio for
predicting death was 8.6 (95% confi-
dence interval: 1.5, 48.3; P  .001) for
RV/LV ratio and 1.5 (95% confidence
interval: 1.05, 2.03; P  .025) for azy-
gos vein diameter.
Interreader Agreement
For quantitative measurements, the
Spearman correlation coefficient ranged
from 0.726 to 0.973 (P  .001), indicat-
ing high agreement between readers. For
qualitative parameters, the  coefficient
ranged from 0.755 to more than 0.99,
indicating good to excellent agreement.
Table 1





(n  12) P Value
PA obstruction (%)*
Miller et al (30) 97 (58, 100) 100 (91, 100) .158
Walsh et al (31) 64 (41, 67) 66.6 (61, 67) .215
Qanadli et al (17) 51 (31, 58) 56.9 (51, 58) .092
Mastora et al (18) 40 (20, 55) 49 (42, 60) .102
PA diameter (mm) 30.4 4.2 32.2 3.8 .195
Aorta diameter (mm) 32.7 4.8 36.1 4.5 .040
PA/aorta ratio 0.9 0.1 0.9 0.1 .298
RV short axis (mm) 47.2 10.0 54.5 7.8 .022
LV short axis (mm) 38.3 6.6 33.5 8.1 .102
RV/LV ratio 1.3 0.4 1.8 0.6 .011
Superior vena cava diameter (mm) 18.9 4.1 23.2 4.6 .001
Azygos vein diameter (mm) 9.3 2.1 13.1 5.3 .001
Note.—Unless otherwise indicated, data are the mean  standard deviation.
* Data are the median, with first and third quartiles in parentheses.
Table 2
Correlation between PA Clot Load and Cardiovascular Measurements
Measurement









PA diameter 0.077 .505 0.012 .920 0.068 .553 0.028 .807
Aorta diameter 0.183 .112 0.156 .174 0.173 .131 0.144 .214
PA/aorta ratio 0.113 .330 0.149 .196 0.114 .322 0.193 .094
RV short axis 0.339 .003 0.300 .008 0.420 .001 0.360 .001
LV short axis 0.386 .001 0.401 .001 0.411 .001 0.509 .001
RV/LV ratio 0.416 .001 0.393 .001 0.494 .001 0.515 .001
Superior vena cava diameter 0.114 .324 0.049 .686 0.154 .181 0.147 .206
Azygos vein diameter 0.187 .105 0.159 .176 0.232 .043 0.242 .037
Note.—Correlation coefficients were calculated by using the Pearson correlation coefficient.
THORACIC IMAGING:Predictors of Mortality for Severe Pulmonary Embolism Ghaye et al
Radiology: Volume 239: Number 3—June 2006 887
Discussion
The findings of this study show that, in
patients admitted for severe PE-related
conditions, RV/LV ratio and azygos vein
diameter, as measured at CT pulmo-
nary angiography, are the best predic-
tors of survival, enabling correct predic-
tion of survival in 89% of patients. De-
spite their differences, the various
systems for scoring PA clot load pro-
vided highly correlated scores, but no
system appropriately discriminated be-
tween survivors and nonsurvivors. In
two previous CT pulmonary angio-
graphic studies, Wu et al (21) and van
der Meer et al (22) reported that the
score obtained with the system pro-
posed by Qanadli et al (17) is an ade-
quate predictor of survival. The median
scores obtained by Wu et al and van der
Meer et al (10% and 32%, respectively)
were lower than those obtained in our
study (52%), which reflects differences
in the populations studied. On the other
hand, we found a correlation between
PA clot load (as estimated with all four
systems) and RV short axis, LV short
axis, and RV/LV ratio and confirmed the
relationship between RV/LV ratio (as
measured at echocardiography or CT
pulmonary angiography) and the score
obtained with the system proposed by
Qanadli et al (17,22).
In accordance with the report by
Collomb et al (19), findings from our
study show that, for patients admitted
to the intensive care unit, PA clot load
indicates the extent of the clot but does
not predict RV failure or death. In PE,
the pulmonary vascular resistance is in-
deed increased not only by mechanical
arterial obstruction but also by vaso-
active agents, vasoconstriction reflex,
and/or systemic arterial hypoxemia
(4,34). Furthermore, in the systems
proposed by Miller et al (30), Walsh et
al (31), and Mastora et al (18), the seg-
mental PAs are the most distal arteries
that can be assessed; the system pro-
posed Qanadli et al (17) includes sub-
segmental PAs. In other words, none of
these systems address clots located dis-
tal to subsegmental arteries. In addi-
tion, none consider sequelae of previous
episodes or associated disorders, such
as chronic obstructive pulmonary dis-
ease, which can contribute to pulmo-
nary hypertension (4).
In previous studies based on angiog-
raphy or scintigraphy results (35–38),
researchers found that RV failure re-
sulting from both arterial obstruction
and underlying cardiopulmonary condi-
tions is a better determinant of mortal-
ity than PA clot load alone. In acute PE
with severe arterial pulmonary hyper-
tension, RV dilation results in an in-
creased RV/LV ratio. In our study, this
ratio was significantly different between
nonsurvivors (mean, 1.8) and survivors
(mean, 1.3). In terms of probability, an
RV/LV ratio of 1 or less is associated
with a 5% likelihood of death, which is
close to the mortality rate in all patients
with treated PE (2,37,39). Results from
Receiver operating characteristic
curves of four CT measurements
tested for their ability to predict
survival for whichAz was signifi-
cantly higher than 0.5. These val-
ues were not significantly different
(P .389 –.865).
Table 3
Performance of CT Measurements for Discrimination of Survivors from Nonsurvivors,





Specificity (%)†Value* P Value
PA clot load score
Miller et al (30) 0.624 (0.436, 0.813) .193 NA NA
Walsh et al (31) 0.617 (0.428, 0.806) .218 NA NA
Qanadli et al (17) 0.659 (0.473, 0.846) .094 NA NA
Mastora et al (18) 0.655 (0.468, 0.842) .102 NA NA
Aorta diameter 0.694 (0.511, 0.877) .039 34.5 mm 64
RV/LV ratio 0.742 (0.565, 0.918) .009 1.5 69
Superior vena cava diameter 0.762 (0.589, 0.934) .004 20.9 mm 69
Azygos vein diameter 0.775 (0.605, 0.945) .003 10.4 mm 70
Note.—Az values were calculated and tested for difference from 0.5. For Az values that demonstrated difference from 0.5,
threshold values were calculated for which sensitivity equaled specificity.
* Data in parentheses are 95% confidence intervals.
† NA  not applicable.
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the receiver operating characteristic
analysis indicate that when the RV/LV
ratio is 1.5, the sensitivity equals speci-
ficity (ie, 69%) for discriminating be-
tween survivors and nonsurvivors.
These results do not confirm those
of Araoz et al (20), who reported an
absence of correlation between cardiac
CT measurements and mortality rate.
The 173 patients included in their study
had PE of low to moderate severity, a
mean RV/LV ratio of 1.1, and a subse-
quent mortality rate of 5%. On the
other hand, our results confirm those of
van der Meer et al (22), who reported a
significantly higher RV/LV ratio in non-
survivors (mean, 1.5) than in survivors
(mean, 1.1).
The cardiac measurements and ra-
tios obtained with CT pulmonary an-
giography could be different from those
obtained with a four-chamber view, as
obtained at echocardiography. Quiroz
et al (26) reported that an RV/LV ratio
of more than 0.9 is a significant predic-
tor of adverse clinical events when mea-
sured on reconstructed CT four-cham-
ber views but not on transverse CT sec-
tions. More recently, investigators (27)
also reported a higher mortality rate in
patients who had an RV/LV ratio of
more than 0.9 on four-chamber views
compared with those who had an
RV/LV ratio of 0.9 or less.
Among vascular measurements, the
mean diameters of the azygos vein, su-
perior vena cava, and aorta were higher
in nonsurvivors than in survivors. Col-
lomb et al (19) also found differences in
the diameter of the superior vena cava
between patients with severe PE, non-
severe PE, or no PE. After investigating
chest radiographs, Pistolesi et al (40)
reported upstream manifestations of
right-sided heart insufficiency in sys-
temic veins and showed significant cor-
relations between right atrial pressure
and superior vena cava and azygos vein
diameters. Conversely, other investiga-
tors have shown significant correlations
between right-sided heart hemodynam-
ics and the diameter of the inferior vena
cava, as measured with ultrasonogra-
phy (41,42).
Among the qualitative findings con-
sidered in our study, reflux of contrast
medium into the inferior vena cava is
the only finding that can be used to dis-
criminate between nonsurvivors and
survivors. The leftward bowing of the
interventricular septum does not seem
to do so, which confirms the results of
studies by Araoz et al (20) and van der
Meer et al (22). Some investigators
(19,20) have nevertheless reported that
leftward bowing of the interventricular
septum may be an indicator of the clini-
cal severity of PE. This could be ex-
plained by the fact that (a) these inves-
tigators considered flattening of the in-
terventricular septum as an indicator of
leftward bowing and (b) such a finding
could be dependant on the x-ray tube
rotation time and therefore may not be
detectable with a 1-second rotation
time, as was used in our study.
Concerning early mortality, the best
parameters for discriminating between
survivors and nonsurvivors are the
same as those for determining overall
in-hospital mortality. In addition, de-
creased LV short axis and pericardial
effusion are supplementary findings that
were more frequent in patients who
died within the first 48 hours than in
those who survived beyond 48 hours.
However, because of the small number
of patients with pericardial effusion, we
cannot draw definite conclusions about
this association.
Several limitations in our study war-
rant consideration. First, its retrospec-
tive design prevented us from producing
correlations with findings of other diag-
nostic tests, especially echocardiogra-
phy. Second, our study group consisted
of patients admitted to the intensive
care unit for severe PE-related condi-
tions. Consequently, we were unable to
evaluate patients with nonsevere PE-re-
lated conditions whose mortality is
lower (2). Third, we did not classify pa-
tients into subgroups according to their
history of associated cardiopulmonary
Table 4
Threshold Values of Quantitative Measurements as Predictive Indices of Death
Measurement
Probability of Death
5% 10% 20% 30% 40% 50%
PA obstruction (%)
Qanadli et al (17) 27 43 60 72 81 90
Mastora et al (18) 5 30 57 75 90 100
RV/LV ratio 1.0 1.3 1.7 1.9 2.1 2.3
RV short axis (mm) 40 48 57 61 65 69
Superior vena cava diameter (mm) 16 19 23 25 27 29
Azygos vein diameter (mm) 7 9 12 13 14 15
Table 5





(n  12) P Value
Pleural effusion 26/70 (37) 6/12 (50) .405
Pericardial effusion 4/70 (6) 2/12 (17) .183
Pulmonary infarct 33/70 (47) 6/12 (50) .891
Platelike atelectasis 51/70 (73) 10/12 (83) .449
Pulmonary consolidation 8/70 (11) 2/12 (17) .614
Mosaic ground-glass opacity 38/70 (54) 6/12 (50) .748
Reflux into inferior vena cava 8/41 (20) 5/9 (56) .026
Interventricular septum bowing 16/70 (23) 3/12 (25) .873
Note.—Numbers in parentheses are percentages.
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disease. Because of the patients’ poor
condition, it was very difficult to estab-
lish such an assessment at admission to
the intensive care unit. Fourth, our re-
sults are limited to the in-hospital stay.
Investigators have reported, however,
that 90% of nonsurvivors die within the
first hours or days after the onset of
symptoms and that very few die after
discharge (1,2,4). Fifth, our study was
based on single–detector row helical CT
scans, but a collimation of 2 mm is ade-
quate to evaluate the PA at the segmen-
tal level and allows accurate cardiac
measurements (12,19,23,24,43).
In conclusion, the findings of CT pul-
monary angiography are adequate for
predicting the prognosis of patients with
severe PE-related conditions, and
RV/LV ratio and azygos vein diameter
are the most accurate predictors of
mortality.
Appendix
The following parameters were used for
the scoring system proposed by Miller
et al (30): The right PA has nine major
segmental branches (three to the upper
lobe, two to the middle lobe, and four to
the lower lobe). The left PA has seven
major branches (two to the upper lobe,
two to the lingula, and three to the
lower lobe). One point is scored for the
presence of a filling defect or obstruc-
tion in any one of these branches. A
filling defect that is proximal to the seg-
mental branches is given a value equal
to the number of segmental branches
that arise distally. The maximum score
is 9 for the right lung and 7 for the left
lung. The maximum possible CT ob-
struction score is 16 for both lungs. In
addition, the score was originally used
to evaluate the effect of embolism on PA
flow, which currently cannot be as-
sessed with CT pulmonary angiography.
In the scoring system by Walsh et al
(31), different scores are assigned for
filling defects and obstructions, depend-
ing on their anatomic locations. The fol-
lowing guidelines are used: (a) filling de-
fects or occlusions in a single segmental
PA may receive a total score that does
not exceed 1, regardless of their num-
ber; (b) abnormalities may receive a to-
tal maximum score of 3 for a single up-
per lobar region, 2 for the middle lobe
or lingula, and 4 for the lower lobes
(occlusion is given a score of 3 for the
upper lobe, 2 for the middle lobe or
lingula, and 4 for the lower lobe,
whereas any lobar filling defect is given
a score of 2); (c) obstructions in central
anatomic regions receive scores accord-
ing to the vessel involved (9 for the main
PA and 6 for the interlobar PAs); (d) if
the total score for one lung is greater
than 4 without the inclusion of filling
defects in central regions, the central
filling defects are ignored; all filling de-
fects in a single central region, whether
single or multiple, receive a score of 3;
(e) if a single vessel contains both a
filling defect and an obstruction, only
the obstruction is scored; and (f) the
sum of scores for all abnormalities in
one lung may not exceed 9. The maxi-
mum CT obstruction score is 18.
In the scoring system by Qanadli et
al (17), the arterial tree of each lung is
regarded as having 10 segmental PAs
(three to the upper lobes, two to the
middle lobe or the lingula, and five to
the lower lobes). An embolus in a seg-
mental PA is given a score of 1, and
emboli at the most proximal arterial
level are given a value that is equal to
the number of segmental PAs that arise
distally. To provide additional informa-
tion on the residual perfusion distal to
the embolus, a weighting factor is used
for each value (0 indicates no defect; 1,
partial occlusion; and 2, complete occlu-
sion). An isolated subsegmental embo-
lus is considered a partially occluded
segmental PA and assigned a value of 1.
The maximum CT obstruction index is
40.
In the scoring system by Mastora et
al (18), scoring is applied to five medias-
tinal PAs (PA trunk, right and left PAs,
and right and left interlobar PAs), six
lobar PAs, and 20 segmental PAs (three
in the upper lobes, two in the middle
lobe or lingula, and five in the lower
lobes). The CT severity score is based
on the percentage of obstruction on the
surface of each central and peripheral
PA section and is scored by using a five-
point scale (1, 25% obstruction; 2,
25%–49%; 3, 50%–74%; 4, 75%–99%;
and 5, 100%). A central score (medias-
tinal and lobar PAs), a peripheral score
(segmental PAs), and a global score
(central and peripheral pulmonary PA)
can then be calculated. The maximum
CT obstruction score is 155.
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